Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models

[1]  S. Batra,et al.  Engineering antibodies for clinical applications. , 2007, Trends in biotechnology.

[2]  T. Oliphant,et al.  Protective and Therapeutic Capacity of Human Single-Chain Fv-Fc Fusion Proteins against West Nile Virus , 2005, Journal of Virology.

[3]  D. Sblattero,et al.  Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. , 2005, Blood.

[4]  Tarcisio Not,et al.  Characterizing monoclonal antibody epitopes by filtered gene fragment phage display. , 2005, The Biochemical journal.

[5]  D. Hicklin,et al.  A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity* , 2005, Journal of Biological Chemistry.

[6]  K. Jooss,et al.  Stable antibody expression at therapeutic levels using the 2A peptide , 2005, Nature Biotechnology.

[7]  Louis M. Weiner,et al.  Bispecific Minibodies Targeting HER2/neu and CD16 Exhibit Improved Tumor Lysis When Placed in a Divalent Tumor Antigen Binding Format* , 2004, Journal of Biological Chemistry.

[8]  I. Sandlie,et al.  Monoclonal antibodies produced by muscle after plasmid injection and electroporation. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  A. Bradbury,et al.  Antibodies in proteomics II: screening, high-throughput characterization and downstream applications. , 2003, Trends in biotechnology.

[10]  A. Bradbury,et al.  Antibodies in proteomics I: generating antibodies. , 2003, Trends in biotechnology.

[11]  L. Adorini.  Tolerogenic Dendritic Cells Induced by Vitamin D Receptor Ligands Enhance Regulatory T Cells Inhibiting Autoimmune Diabetes , 2003, Annals of the New York Academy of Sciences.

[12]  S. Batra,et al.  Pharmacokinetics and biodistribution of genetically engineered antibodies. , 2002, Current opinion in biotechnology.

[13]  R. Marzari,et al.  The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments. , 2002, European journal of biochemistry.

[14]  Philip R. Johnson,et al.  Generation of Neutralizing Activity against Human Immunodeficiency Virus Type 1 in Serum by Antibody Gene Transfer , 2002, Journal of Virology.

[15]  D. Noël,et al.  High in vivo production of a model monoclonal antibody on adenoviral gene transfer. , 2002, Human gene therapy.

[16]  F. Paparo,et al.  Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ , 2002, Gut.

[17]  Fuchun Zhou,et al.  Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets. , 2002, Vaccine.

[18]  T. Flotte,et al.  Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Reff,et al.  A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications. , 2001, Critical reviews in oncology/hematology.

[20]  R E Fulton,et al.  Bispecific and bifunctional single chain recombinant antibodies. , 2001, Biomolecular engineering.

[21]  M. Vogel,et al.  Isolation and functional characterization of recombinant GAD65 autoantibodies derived by IgG repertoire cloning from patients with type 1 diabetes. , 2001, Diabetes.

[22]  R. Samulski,et al.  Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  Philippa Marrack,et al.  Autoimmune disease: why and where it occurs , 2001, Nature Medicine.

[24]  R Carlsson,et al.  Human therapeutic antibodies. , 2001, Current opinion in pharmacology.

[25]  E. Tongiorgi,et al.  Molecular Dissection of the Tissue Transglutaminase Autoantibody Response in Celiac Disease1 , 2001, The Journal of Immunology.

[26]  R. Marzari,et al.  Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease , 2000, American Journal of Gastroenterology.

[27]  F. Benvenuti,et al.  Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection , 2000, Gene Therapy.

[28]  Y. Koide,et al.  Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. , 2000, Vaccine.

[29]  J. Ledbetter,et al.  Characterization of scFv-Ig constructs generated from the anti-CD20 mAb 1F5 using linker peptides of varying lengths. , 1999, Journal of immunology.

[30]  D. Burton,et al.  Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis , 1998, Journal of Neuroimmunology.

[31]  E. Raz,et al.  Gene vaccination: plasmid DNA is more than just a blueprint. , 1998, Immunology today.

[32]  H. Herweijer,et al.  High expression of naked plasmid DNA in muscles of young rodents. , 1997, Human molecular genetics.

[33]  J. Schlom,et al.  In vivo gene inoculation of a recombinant single-chain antitumor antibody induces anti-immunoglobulin response. , 1997, Cancer gene therapy.

[34]  D. Schuppan,et al.  Identification of tissue transglutaminase as the autoantigen of celiac disease , 1997, Nature Medicine.

[35]  O. Burrone,et al.  Mammalian cell expression of dimeric small immune proteins (SIP). , 1997, Protein engineering.

[36]  D. Burton,et al.  Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. , 1997, Journal of immunology.

[37]  S. Morrison,et al.  Design and production of novel tetravalent bispecific antibodies , 1997, Nature Biotechnology.

[38]  J. Lecerf,et al.  Repertoire cloning of lupus anti-DNA autoantibodies. , 1996, The Journal of clinical investigation.

[39]  R. Levy,et al.  DNA immunization induces protective immunity against B–cell lymphoma , 1996, Nature Medicine.

[40]  A. Weetman,et al.  Cloning and analysis of IgG kappa and IgG lambda anti-thyroglobulin autoantibodies from a patient with Hashimoto's thyroiditis: evidence for in vivo antigen-driven repertoire selection. , 1996, Journal of immunology.

[41]  J. Schlom,et al.  Expression of a tumor-reactive antibody-interleukin 2 fusion protein after in vivo particle-mediated gene delivery. , 1995, Cancer gene therapy.

[42]  M. Goggins,et al.  Celiac disease and other nutrient related injuries to the gastrointestinal tract. , 1994, The American journal of gastroenterology.

[43]  A. Plückthun,et al.  Improved Bivalent Miniantibodies, with Identical Avidity as Whole Antibodies, Produced by High Cell Density Fermentation of Escherichia coli , 1993, Nature Biotechnology.

[44]  S. Morrison,et al.  Structural features of human immunoglobulin G that determine isotype- specific differences in complement activation , 1993, The Journal of experimental medicine.

[45]  R. Randall,et al.  Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. , 1992, The Journal of general virology.

[46]  H R Hoogenboom,et al.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage. , 1991, Journal of molecular biology.

[47]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[48]  R. Dwek,et al.  Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay. , 1984, Molecular immunology.

[49]  H. Bazin,et al.  Classes and subclasses of rat antibodies: reaction with the antigen and interaction of the complex with the complement system. , 1981, Immunology.

[50]  O. Burrone,et al.  Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants. , 2001, Gene therapy.

[51]  Daniele Sblattero,et al.  Exploiting recombination in single bacteria to make large phage antibody libraries , 2000, Nature Biotechnology.